Exploration of the optimized portrait of omega-3 polyunsaturated fatty acids in treating depression: A meta-analysis of randomized-controlled trials
Abstract
BACKGROUND
According to previous studies, omega-3 polyunsaturated fatty acids (PUFAs) are controversial for the efficacy of treating depression.
AIMS
This meta-analysis aims to investigate whether omega-3 PUFAs are able to treat depression, and find out the most beneficial clinical portrait.
METHODS
More than two reviewers searched six registries, and 36 studies were eventually considered eligible. The PRISMA guidelines were used for data extraction, Cochrane Handbook for quality assessment, and random effects model for data pooling.
OUTCOMES
Significant heterogeneity and publication bias were observed. According to the results, significant efficacy was detected in the overall analysis [SMD = -0.26, 95 % CI = (-0.41, -0.11)] and several subgroups, while total daily dosage might be a potential heterogeneity source (P < 0.05). No between-group difference was observed in the rate of response [RR = 0.99, 95 % CI = (0.82, 1.20)], remission [RR = 1.17, 95 % CI = (0.92, 1.48)], and adverse events [RR = 1.07, 95 % CI = (0.90, 1.29)]. Total daily intake of eicosapentaenoic acid (EPA) and remission rate conformed to linear correlation (P < 0.05).
CONCLUSIONS
1) Omega-3 PUFAs might be effective in treating depression; 2) For Asian patients with mild to moderate depression and no other baseline medication, over 8 weeks of omega-3 PUFAs 1000-1500 mg/day with ratio of EPA/docosahexaenoic acid (DHA) between 1:1 and 2:1 might benefit the most; 3) Omega-3 PUFAs are no superior than placebo…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.